Synthesis, characterization and Molecular docking simulation of novel Atorvastatin Aspirin ester, and study activation effect on lactate dehydrogenase enzyme in atherosclerosis patient
Article Sidebar
Main Article Content
Abstract
This study involved synthesis of Atorvastatin Aspirin ester prodrug by reacting of aspirin drug with thionyl chloride SOCl2 to produce aspirinyl chloride that mixed with Atorvastatin drug which dissolved with acetone to produce corresponding ester. The structure of new compound was estabilished by spectral techniques that includes FT-IR and 1H-NMR. The biochemical part encompassed collecting of blood samples from atherosclerosis patients then many diluted concentrations of new prepared prodrug and study its effect on the lactate dehydrogenase activity where the outcomes indicated the new ester have activation effect on lactate dehydrogenase enzyme. Molecular docking study was a theoretical investigation to study the interaction of new synthesized ester with Lactate dehydrogenase enzyme (PDB:ID=4i8x), the molecular docking study clarified the synthesized compound showed good docking score: -8.9 kcal\mol with RMSD value 2.819, 5.803 Ao, and binding patterns
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Tikrit Journal of Pure Science is licensed under the Creative Commons Attribution 4.0 International License, which allows users to copy, create extracts, abstracts, and new works from the article, alter and revise the article, and make commercial use of the article (including reuse and/or resale of the article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made, and the licensor is not represented as endorsing the use made of the work. The authors hold the copyright for their published work on the Tikrit J. Pure Sci. website, while Tikrit J. Pure Sci. is responsible for appreciate citation of their work, which is released under CC-BY-4.0, enabling the unrestricted use, distribution, and reproduction of an article in any medium, provided that the original work is properly cited.
References
1. Lennernäs H. Clinical pharmacokinetics of atorvastatin. Clinical pharmacokinetics. 2003;42:1141-60. https://doi.org/10.2165/00003088-200342130-00005
2. Gheorghe G, Toth PP, Bungau S, Behl T, Ilie M, Pantea Stoian A, et al. Cardiovascular risk and statin therapy considerations in women. Diagnostics. 2020;10(7):483. https://www.mdpi.com/2075-4418/10/7/483#
3. Jin HMSYS. Discovering New Crystalline Forms of Atorvastatin Calcium-New Strategies for Screening. 2012.
4. Pak VV, Kwon DY, Khojimatov OK, Pak AV, Sagdullaev SS. Design of Tripeptides as a Competitive Inhibitor for HMG-CoA Reductase. International Journal of Peptide Research and Therapeutics. 2021;27(3):1923-31. https://doi.org/10.1007/s10989-021-10221-z
5. Jo Y, DeBose-Boyd RA. Post-translational regulation of HMG CoA reductase. Cold Spring Harbor Perspectives in Biology. 2022;14(12):a041253. https://doi.org/10.1101/cshperspect.a041253
6. Pangestika I, Oksal E, Muhammad TST, Amir H, Syamsumir DF, Wahid MEA, et al. Inhibitory effects of tangeretin and trans-ethyl caffeate on the HMG-CoA reductase activity: Potential agents for reducing cholesterol levels. Saudi Journal of Biological Sciences. 2020;27(8):1947-60. https://doi.org/10.1016/j.sjbs.2020.06.010
7. Chen Y-C, Qiang G-F, Du G-H. Salicylic acid. Natural Small Molecule Drugs from Plants. 2018:455-9. https://doi.org/10.1007/978-981-10-8022-7
8. Leggat PA. A brief history of the discovery and applications of aspirin. Annals of the ACTM: An International Journal of Tropical and Travel Medicine. 2012;13(1):5-9.
9. DPh DAV. An Abridged History of ASPIRIN. International Journal of Pharmaceutical Compounding. 2009;13(5):404.
10. Yeomans ND. Aspirin: old drug, new uses and challenges. Journal of gastroenterology and hepatology. 2011;26(3):426-31. https://doi.org/10.1111/j.1440-1746.2010.06569.x
11. Capodanno D, Mehran R, Valgimigli M, Baber U, Windecker S, Vranckx P, et al. Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention. Nature Reviews Cardiology. 2018;15(8):480-96. https://doi.org/10.1038/s41569-018-0049-1
12. Newburger J. Committee on rheumatic fever, endocarditis and Kawasaki disease; council on cardiovascular disease in the young; American Heart Association; American Academy of Pediatrics. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis and Kawasaki disease, council on cardiovascular disease in the young, American Heart Association. Circulation. 2004;110:2747-71. https://doi.org/10.1161/01.CIR.0000145143.19711.78
13. Jadhav KB, Khirnar HR, Ishi HS, Borse S, Borse L, Pawar S. A review on prodrug. Pharm Sci Monitor. 2015;6:103-17.
14. Redasani VK, Bari SB. Prodrug design: Perspectives, approaches and applications in medicinal chemistry: Academic Press; 2015.
15. Sanches BM, Ferreira EI. Is prodrug design an approach to increase water solubility? International journal of pharmaceutics. 2019;568:118498. https://doi.org/10.1016/j.ijpharm.2019.118498
16. Khan AA, Allemailem KS, Alhumaydhi FA, Gowder SJ, Rahmani AH. The biochemical and clinical perspectives of lactate dehydrogenase: an enyme of active metabolism. Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets-Immune, Endocrine & Metabolic Disorders). 2020;20(6):855-68. https://doi.org/10.2174/1871530320666191230141110
17. Ravenell PB. A biochemical study of gossypol and lactate dehydrogenase-X binary interactions: Old Dominion University and Eastern Virginia Medical School; 1991.
18. Serrano-Lorenzo P, Rabasa M, Esteban J, Hidalgo Mayoral I, Domínguez-González C, Blanco-Echevarría A, et al. Clinical, biochemical, and molecular characterization of two families with novel mutations in the LDHA gene (GSD XI). Genes. 2022;13(10):1835. https://www.mdpi.com/2073-4425/13/10/1835#
19. Agarwal S, Mehrotra R. An overview of molecular docking. JSM chem. 2016;4(2):1024-8.
20. Fan J, Fu A, Zhang L. Progress in molecular docking. Quantitative Biology. 2019;7:83-9. https://doi.org/10.1007/s40484-019-0172-y
21. Dawood ZA, Algburi FS, Naji NA. Synthesis of new thioester derivative of aspirin and study its effect on some biochemical parameters in blood serum of rabbits. Tikrit Journal of Pure Science. 2022;27(2):16-22. http://dx.doi.org/10.25130/tjps.27.2022.019
22. Mathieu M, Artur Y, Aubry C, Bailly M, Braun J, Bretaudiere J, et al. Recommendations pour la mesure de la concentration catalytique de la lactate deshydrogenase dans le serum humain a+ 30ºC (dokument F). Ann Biol Clin. 1982;40:123-5.
23. Dawood ZA, Khalid FD, Hameed AS. Synthesis, radical scavenging activity, antibacterial activity and molecular docking of a new thiazolidine-4-one and 1, 3, 4 oxadiazole derivatives of tolfenamic acid. Synthesis. 2022;45(02).